Citigroup Inc Third Harmonic Bio, Inc. Transaction History

Citigroup Inc

  • $153 Billion
  • Q2 2024

A detailed history of Citigroup Inc transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Citigroup Inc holds 5,464 shares of THRD stock, worth $68,901. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,464
Previous 3,944 38.54%
Holding current value
$68,901
Previous $37,000 91.89%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$8.74 - $15.54 $13,284 - $23,620
1,520 Added 38.54%
5,464 $71,000
Q1 2024

May 10, 2024
BUY
$8.6 - $11.24 $3,156 - $4,125
367 Added 10.26%
3,944 $37,000
Q4 2023

Feb 09, 2024
BUY
$5.97 - $11.47 $21,300 - $40,924
3,568 Added 39644.44%
3,577 $39,000
Q3 2023

Nov 09, 2023
SELL
$4.92 - $7.09 $28,496 - $41,065
-5,792 Reduced 99.84%
9 $0
Q2 2023

Aug 10, 2023
BUY
$4.18 - $5.33 $24,248 - $30,919
5,801 New
5,801 $27,000
Q4 2022

Feb 09, 2023
BUY
$4.0 - $23.97 $1,656 - $9,923
414 New
414 $1,000

Others Institutions Holding THRD

# of Institutions
74
Shares Held
40.2M
Call Options Held
9.1K
Put Options Held
0
View Full List

About Third Harmonic Bio, Inc.

THRD Quotes by TradingView
  • Ticker THRD
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,328,900
  • Market Cap $509M
More about THRD
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email